Evaluation of cranial nerve mononeuropathy

Last reviewed: 15 Mar 2025
Last updated: 09 Apr 2025

Summary

Differentials

Common

  • Giant cell arteritis (II, III, IV, VI)
  • Non-arteritic anterior ischemic optic neuropathy (II)
  • Multiple sclerosis (II)
  • Viral infection (II)
  • Subarachnoid hemorrhage (III, IV, VI)
  • Meningitis (III, IV, VI)
  • Vascular malformations (V)
  • Herpes zoster (V)
  • Multiple sclerosis (V)
  • Bell palsy (VII)
  • Ramsay Hunt syndrome (VII)
  • Ischemic stroke (VII)
  • Vestibular neuritis (VIII)
  • Neural presbycusis (VIII)
  • Drugs (VIII)
  • Iatrogenic (X)
  • Apical lung tumor (IX, X)
  • Iatrogenic (XI)
  • Ischemic stroke (XII)
Full details

Uncommon

  • Trauma (I)
  • Neurodegenerative disorders (I)
  • Congenital (I)
  • CNS tumors (I)
  • Optic canal trauma (II)
  • CNS tumors (II)
  • Idiopathic intracranial hypertension (II)
  • Autoimmune disease: (e.g., systemic lupus erythematosus (SLE), Sjogren, granulomatosis with polyangiitis, Behcet disease [II])
  • Leber hereditary optic neuropathy (II)
  • Optical toxins or nutritional deficiency (II)
  • Neuromyelitis optica (II)
  • Uncal herniation (III, IV, VI)
  • Migraine (III, IV, VI)
  • Trauma (III, IV, VI)
  • Cerebral aneurysms (III, IV, VI)
  • Cavernous-carotid fistula (III, IV, VI)
  • Cavernous sinus thrombus (III, IV, VI)
  • CNS tumors (III, IV, VI)
  • Drugs (III, IV, VI)
  • Idiopathic intracranial hypertension (III, IV, VI)
  • Congenital (III, IV, VI)
  • Post-lumbar puncture (VI)
  • Meningitis (V)
  • CNS tumors (V)
  • Autoimmune disorders (V)
  • Skull-base osteomyelitis (V)
  • Trauma (V)
  • Dental abscess (V)
  • Spinal cord lesion (V)
  • Iatrogenic (V)
  • Mandibular tumors (V)
  • Congenital (V)
  • Tolosa-Hunt syndrome (V)
  • Wallenberg syndrome (V)
  • Neurosarcoidosis (VII)
  • CNS tumors (VII)
  • Trauma (VII)
  • Meningitis (VII)
  • Iatrogenic (VII)
  • Middle ear or mastoid infection (VII)
  • Parotid tumor (VII)
  • HIV associated (VII)
  • Lyme disease (VII)
  • CNS tumors (VIII)
  • CNS tumors (IX, X)
  • Parapharyngeal tumor (IX, X)
  • Meningitis (IX, X)
  • Skull-base osteomyelitis (IX, X)
  • Trauma (IX, X)
  • Parapharyngeal space infection (IX, X)
  • Eagle syndrome (IX)
  • Cardiovocal syndrome (X)
  • Trauma (XI)
  • CNS tumors (XI)
  • CNS tumors (XII)
  • Motor neurone disease/Progressive bulbar palsy (XII)
  • Chiari I and II malformations (XII)
  • Extracranial (tongue or neck) or skull-base tumors (XII)
  • Meningitis (XII)
  • Skull-base osteomyelitis (XII)
  • Parapharyngeal space infection (XII)
  • Trauma (XII)
  • Dural arteriovenous fistula (XII)
  • Internal carotid artery aneurysm or dissection (XII)
  • Iatrogenic (XII)
Full details

Contributors

Authors

James B Meiling, DO, RMSK

Assistant Professor

Department of Physical Medicine and Rehabilitation

Mayo Clinic

Rochester

MN

Disclosures

JBM declares that he has no competing interests.

Tatsuya Oishi, MD

Assistant Professor

Department of Neurology

Mayo Clinic

Rochester

MN

Disclosures

TO declares that he has no competing interests.

Acknowledgements

Dr Meiling and Dr Oishi would like to gratefully acknowledge Dr Ann Johnston, Dr Emma Tallantyre, Dr Zachary L. Hickman, Dr Brad E. Zacharia, Dr Christopher J. Winfree, and Dr Adrian J. Wills, the previous contributors to this topic.

Disclosures

AJ has received speaker fees from UCB and Eisai. ET has received honoraria for consulting work from Novartis, Merck, Biogen, and Roche, and received travel grants to attend or speak at educational meetings from Merck, Roche, Takeda, and Novartis. ZLH, BEZ, CJW, and AJW declare that they have no competing interests.

Peer reviewers

Benjamin D. Gallagher, MD, FACP

Assistant Professor of Medicine

Yale School of Medicine

New Haven

CT

Disclosures

BDG declares that he has no competing interests.

Sabrina Ravaglia, MD, PhD

Staff Physician

Department of Neurological Sciences

Institute of Neurology C. Mondino

Pavia

Italy

Disclosures

SR declares that she has no competing interests.

Use of this content is subject to our disclaimer